It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 2 FA rating(s) are green whileBDX’s FA Score has 2 green FA rating(s), and CNMD’s FA Score reflects 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 3 TA indicator(s) are bullish while BDX’s TA Score has 5 bullish TA indicator(s), and CNMD’s TA Score reflects 4 bullish TA indicator(s).
BAX (@Pharmaceuticals: Other) experienced а +1.35% price change this week, while BDX (@Pharmaceuticals: Other) price change was +4.98% , and CNMD (@Medical/Nursing Services) price fluctuated +3.80% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.35%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +5.61%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.87%. For the same industry, the average monthly price growth was +10.40%, and the average quarterly price growth was -10.24%.
BAX is expected to report earnings on Oct 29, 2026.
BDX is expected to report earnings on Nov 05, 2026.
CNMD is expected to report earnings on Oct 28, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+0.87% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| BAX | BDX | CNMD | |
| Capitalization | 13.6B | 51.7B | 1.53B |
| EBITDA | 762M | 4.97B | 188M |
| Gain YTD | 37.711 | 26.027 | 25.936 |
| P/E Ratio | 87.85 | 32.83 | 27.64 |
| Revenue | 11.5B | 22.2B | 1.37B |
| Total Cash | 2.15B | N/A | 37.3M |
| Total Debt | 9.67B | 17.3B | 834M |
BAX | BDX | CNMD | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 86 | 39 | 30 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 7 Undervalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 87 | 100 | |
SMR RATING 1..100 | 95 | 84 | 82 | |
PRICE GROWTH RATING 1..100 | 8 | 9 | 40 | |
P/E GROWTH RATING 1..100 | 30 | 55 | 9 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDX's Valuation (7) in the Medical Specialties industry is in the same range as CNMD (12) and is significantly better than the same rating for BAX (93). This means that BDX's stock grew similarly to CNMD’s and significantly faster than BAX’s over the last 12 months.
BDX's Profit vs Risk Rating (87) in the Medical Specialties industry is in the same range as CNMD (100) and is in the same range as BAX (100). This means that BDX's stock grew similarly to CNMD’s and similarly to BAX’s over the last 12 months.
CNMD's SMR Rating (82) in the Medical Specialties industry is in the same range as BDX (84) and is in the same range as BAX (95). This means that CNMD's stock grew similarly to BDX’s and similarly to BAX’s over the last 12 months.
BAX's Price Growth Rating (8) in the Medical Specialties industry is in the same range as BDX (9) and is in the same range as CNMD (40). This means that BAX's stock grew similarly to BDX’s and similarly to CNMD’s over the last 12 months.
CNMD's P/E Growth Rating (9) in the Medical Specialties industry is in the same range as BAX (30) and is somewhat better than the same rating for BDX (55). This means that CNMD's stock grew similarly to BAX’s and somewhat faster than BDX’s over the last 12 months.
| BAX | BDX | CNMD | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 66% | 2 days ago 67% | 2 days ago 72% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 53% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 70% | 5 days ago 55% | 2 days ago 66% |
| MACD ODDS (%) | 2 days ago 64% | 2 days ago 64% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 47% | 2 days ago 67% |
| TrendMonth ODDS (%) | 2 days ago 65% | 2 days ago 51% | 2 days ago 64% |
| Advances ODDS (%) | 7 days ago 57% | 5 days ago 44% | 6 days ago 69% |
| Declines ODDS (%) | 5 days ago 65% | 8 days ago 43% | 21 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 49% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 64% | 2 days ago 52% | 2 days ago 57% |
A.I.dvisor indicates that over the last year, BAX has been loosely correlated with LUNG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then LUNG could also see price increases.
| Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
|---|---|---|---|---|
| BAX | 100% | -0.75% | ||
| LUNG - BAX | 53% Loosely correlated | +9.65% | ||
| STE - BAX | 51% Loosely correlated | -0.60% | ||
| SYK - BAX | 51% Loosely correlated | +0.85% | ||
| ICUI - BAX | 50% Loosely correlated | -0.17% | ||
| SOLV - BAX | 49% Loosely correlated | +0.39% | ||
More | ||||
A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.
| Ticker / NAME | Correlation To BDX | 1D Price Change % | ||
|---|---|---|---|---|
| BDX | 100% | -0.50% | ||
| COO - BDX | 55% Loosely correlated | -3.64% | ||
| BAX - BDX | 51% Loosely correlated | -0.75% | ||
| TMO - BDX | 50% Loosely correlated | -0.09% | ||
| MMSI - BDX | 50% Loosely correlated | +0.90% | ||
| CNMD - BDX | 48% Loosely correlated | -0.70% | ||
More | ||||
A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with KIDS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then KIDS could also see price increases.
| Ticker / NAME | Correlation To CNMD | 1D Price Change % | ||
|---|---|---|---|---|
| CNMD | 100% | -0.70% | ||
| KIDS - CNMD | 54% Loosely correlated | -2.27% | ||
| ENOV - CNMD | 54% Loosely correlated | +1.47% | ||
| SYK - CNMD | 50% Loosely correlated | +0.85% | ||
| IART - CNMD | 50% Loosely correlated | +0.60% | ||
| NVST - CNMD | 49% Loosely correlated | +0.48% | ||
More | ||||